The Scientist

» clinical trials, culture and disease/medicine

Most Recent

image: FDA OKs Clinical Trials of Ecstasy for PTSD

FDA OKs Clinical Trials of Ecstasy for PTSD

By | December 1, 2016

The illicit drug has shown promise in helping people with debilitating post-traumatic stress disorder.

0 Comments

image: Book Excerpt from <em>Redesigning Life</em>

Book Excerpt from Redesigning Life

By | December 1, 2016

In Chapter 8, author John Parrington explores the intersection of precision genome editing and stem cell technologies.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | December 1, 2016

The importance of science innovation, publishing and gender, and more

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Opinion: Not All Genetic Databases Are Equal

Opinion: Not All Genetic Databases Are Equal

By | December 1, 2016

Sorting out which data sets are clinical-grade is key to helping patients.

0 Comments

image: 2016 Top 10 Innovations: Honorable Mentions

2016 Top 10 Innovations: Honorable Mentions

By | December 1, 2016

These runners up to the Top 10 Innovations of 2016 caught our judges' attention.

0 Comments

image: Opinion: The Impact Factor, Re-envisioned

Opinion: The Impact Factor, Re-envisioned

By , and | November 18, 2016

A combination of the traditional metric and the newer h5 index potentiates the scientific community toward more-balanced evaluation. 

2 Comments

image: More Success Fixing Sickle Cell Gene with CRISPR

More Success Fixing Sickle Cell Gene with CRISPR

By | November 9, 2016

Researchers say they have sufficient in vitro and animal data to apply for human testing.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

Family members with a certain gene variant had unnecessary interventions, highlighting the potential hazards of precision medicine.

2 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Image of the Day: Parting Ways
    Image of the Day Image of the Day: Parting Ways

    The Allen Institute for Cell Science releases the first public collection of human induced pluripotent stem cells that have been fluorescently tagged using CRISPR.

Rockland